The National Development and Reform Commission (NDRC) is considering cutting drug prices by an average 40% on 658 types of medicines in 307 categories. The reductions are detailed in a document that has been seen by pharma executives. Although the NDRC confirmed the document’s existence, it did not answer questions about whether the cuts will be put into effect or estimate a timetable for their implementation.  More details....